Corvus Pharmaceuticals CRVS Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's total operating expenses?
- Corvus Pharmaceuticals (CRVS) reported total operating expenses of $14.88M in Q1 2026.
- How has Corvus Pharmaceuticals's total operating expenses changed year-over-year?
- Corvus Pharmaceuticals's total operating expenses increased by 49.9% year-over-year, from $9.92M to $14.88M.
- What is the long-term trend for Corvus Pharmaceuticals's total operating expenses?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's total operating expenses has grown at a 2.7% compound annual growth rate (CAGR), from $38.63M to $42.97M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.